NCT05593263

Brief Summary

The goal of this is prospective, computer based randomized clinical trial is to compare the efficacy of reduction of the pre-existing corneal astigmatism at the time of cataract surgery in patients admitted in sohag university hospital. the main questions it aims to answer are :

  • Is limbal relaxing incisions as effective as the paired opposite 4mm clear corneal incisions technique in reduction of corneal astigmatism at the time of cataract surgery ?
  • Are both techniques effective in treating mild degrees of corneal Astigmatism ? All participants will have full ophthalmological examination necessary for routine cataract surgery, then randomly divided into 2 groups, clear corneal incision group \& limbal relaxing incision group. Researcher will compare difference between both groups regarding the following :
  • Uncorrected distance visual acuity (UCVA)
  • Best Corrected visual acuity (BCVA)
  • keratometry readings

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 25, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

November 15, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2024

Completed
Last Updated

October 25, 2022

Status Verified

October 1, 2022

Enrollment Period

1 year

First QC Date

October 17, 2022

Last Update Submit

October 20, 2022

Conditions

Keywords

astigmatismlimbal relaxing incisionscataract surgery

Outcome Measures

Primary Outcomes (1)

  • change of corneal astigmatism assessed by K readings measurment

    keratometry readings by autokeratometry, Topcon KR-8900, Tokyo, Japan ) confirmed by Pentacam (Sirius Scheimpflug Placido topography .CSO, Florence, Italy).

    1month post operative , 3 month post operative , 6 month post operative

Secondary Outcomes (1)

  • change of manifest refraction assessed by autorefractometer (Topcon KR-8900, Tokyo,

    1month post operative , 3 month post operative , 6 month post operative

Study Arms (2)

Clear corneal incisions

EXPERIMENTAL

the Steep meridian will be identified and marked, One clear corneal incision will be made on one side of the steep axis using 2.4mm keratome knife then enlarged to 4mm after completion of cataract surgery \& other corneal 4mm incision is added to the other side of the steep axis

Procedure: surgical correction of astigmatism with cataract

Limbal relaxing incision

EXPERIMENTAL

Single or paired LRI will be performed on the steep axis prior to phaco-emulsification procedure using a 600 μm diamond guarded blade.

Procedure: surgical correction of astigmatism with cataract

Interventions

The Steep meridian will be identified and marked, relaxing limbal / corneal incisions will be designed according to it.

Clear corneal incisionsLimbal relaxing incision

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cataract patients aged 21- 80 years.
  • keratometric astigmatism 1D - 4D.
  • Healthy clear cornea

You may not qualify if:

  • History of previous keratorefractive or anterior segment surgery.
  • Previous ocular trauma .
  • Corneal scar or opacities.
  • Irregular corneal astigmatism.
  • Cataract unsuitable for phacoemulsification.
  • Ongoing chronic ocular pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Astigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Candidates will be randomly divided into two groups, OCCE group \& LRI group before their cataract surgery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer of opthalmology

Study Record Dates

First Submitted

October 17, 2022

First Posted

October 25, 2022

Study Start

November 15, 2022

Primary Completion

November 15, 2023

Study Completion

February 15, 2024

Last Updated

October 25, 2022

Record last verified: 2022-10